Alyce E Roen, | |
1750 W Broadway, Council Bluffs, IA 51501-3814 | |
(712) 215-6588 | |
(712) 322-9585 |
Full Name | Alyce E Roen |
---|---|
Gender | Female |
Speciality | Behavior Technician |
Location | 1750 W Broadway, Council Bluffs, Iowa |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104608884 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | (Iowa) | Secondary |
106S00000X | Behavior Technician | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alyce E Roen, 1750 W Broadway, Council Bluffs, IA 51501-3814 Ph: (712) 215-6588 | Alyce E Roen, 1750 W Broadway, Council Bluffs, IA 51501-3814 Ph: (712) 215-6588 |
News Archive
An investigation into factors related to disparities of depression in young adults has found that higher parental education - which has a protective effect for white youth - can also increase the risk of depression for black youth.
Reuters examines abortion, contraception and sex education in Russia, where, "two decades after the Soviet Union's collapse, wider availability of contraception and a resurgence of religion have reduced the numbers of abortions overall, but termination remains the top method of birth control in Russia."
Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants (or "bionic ears"), announced today that it has entered into a definitive merger agreement with Sonova Holding AG, the world's leading provider of hearing systems.
NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMistâ„¢ in the United States and Canada. ZolpiMistâ„¢ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.
Contrary to prevailing assumptions, children are more vulnerable to the harmful effects of lead exposure at the age of 6 than they are in early childhood, according to a Cincinnati Children's Hospital Medical Center study to be presented May 4 at the annual meeting of the Pediatric Academic Societies in Honolulu.
› Verified 6 days ago